Examining the mechanism of Erk nuclear translocation using green fluorescent protein

Experimental Cell Research

Volumn 285, Issue 2, 2003, Pages 208-220

  Horgan, Angela M ^a   Stork, Philip J S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ERKs; GFP; Nuclear translocation; PC12 cells

Indexed keywords

EPIDERMAL GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NUCLEAR PROTEIN; RECEPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN; CELL TRANSPORT; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT;

EID: 0037403309     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00037-5     Document Type: Article

References (48)

1. Alest L.V., Barr M., Marcus S., Polverino A., Wigler M. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA. 90:1993;6213-6217.
2. Butch E.R., Guan K.L. Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2. J. Biol. Chem. 271:1996;4230-4235.
3. Seth A., Alvarez E., Gupta S., Davis R.J. A phosphorylation site located in the NH2-terminal domain of c-Myc is required for transactivation of gene expression. J. Biol. Chem. 266:1991;23521-23524.
4. Xing J., Kornhauser J.M., Zhengui X., Thiele E.A., Greenberg M.E. Nerve growth factor activates extracellular signal-related kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18:1998;1946-1955.
5. Marshall C.J. Specificity of receptor tyrosine kinase signaling transient versus sustained extracellular signal-regulated kinase activation . Cell. 80:1995;179-185.
6. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouyssegur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18:1999;664-674.
7. Hochholdinger F., Baier G., Nogalo A., Bauer B., Grunicke H.H., Uberall F. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells. Mol. Cell. Biol. 19:1999;8052-8065.
8. Alberola-Ila J., Forbush K.A., Seger R., Krebs E.G., Perlmutter R.M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:1995;620-623.
9. Rebay I., Rubin G.M. Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell. 81:1995;857-866.
10. Sale E.M., Atkinson P.G., Sale G.J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 14:1995;674-684.
11. Whalen A.M., Galasinski S.C., Shapiro P.S., Nahreini T.S., Ahn N.G. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17:1997;1947-1958.
12. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
13. Nguyen T.T., Scimeca J.C., Filloux C., Peraldi P., Carpentier J.L., Van Obberghen E. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor. J. Biol. Chem. 268:1993;9803-9810.
14. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem. J. 288:1992;351-355.
15. Robinson M.J., Stippec S.A., Goldsmith E., White M.A., Cobb M.H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8:1998;1141-1150.
16. Martin K., Michael D., Rose J., Barad M., Casadio A., Zhu H., Kandel E. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in aplysia. Neuron. 18:1997;899-912.
17. English J.D., Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272:1997;19103-19106.
18. Patterson S.L., Pittenger C., Morozov A., Martin K.C., Scanlin H., Drake C., Kandel E.R. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron. 32:2001;123-140.
19. Adachi M., Fukuda M., Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase passive diffusion of a monomer and active transport of a dimer . EMBO J. 18:1999;5347-5358.
20. Rubenfeld H., Hanoch T., Seger R. Identification of a cytoplasmic retention squence in ERK2. J. Biol. Chem. 274:1999;30349-30352.
21. Blanco-Aparicio C., Torres J., Pulido R. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell Biol. 147:1999;1129-1136.
22. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron. 21:1998;869-883.
23. Vossler M., Yao H., York R., Rim C., Pan M.-G., Stork P.J.S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
24. Misra-Press A., Rim C.S., Yao H., Roberson M.S., Stork P.J.S. A novel mitogen-activated protein kinase phosphatase structure, expression and regulation . J. Biol. Chem. 270:1995;14587-14596.
25. Fukuda M., Gotoh Y., Nishida E. Interaction of MAP kinase with MAP kinase kinase its possible role in the control of nucleocytoplasmic transport of MAP kinase . EMBO J. 16:1997;1901-1908.
26. mapkk) in fibroblasts. J. Cell Biol. 122:1993;1079-1088.
27. Fukuda M., Gotoh I., Gotoh Y., Nishida E. Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:1996;20024-20028.
28. Grewal S.S., Horgan A.M., York R.D., Withers G.S., Banker G.A., Stork P.J. Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J. Biol. Chem. 275:2000;3722-3728.
29. Perron J.C., Bixby J.L. Distinct neurite outgrowth signaling pathways converge on ERK activation. Mol. Cell. Neurosci. 13:1999;362-378.
30. Traverse S., Chohen P. Identification of a latent MAP kinase kinase kinase in PC12 cells as B-raf. FEBS Lett. 350:1994;13-18.
31. Chao M.V. Growth factor signaling where is the specificity . Cell. 68:1992;995.
32. Gotoh Y., Nishida E., Yamashita T., Hoshi M., Kawakami M., Sakai H. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Eur. J. Biochem. 193:1990;661-669.
33. Chen R.-H., Sarnecki C., Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12:1992;915-927.
34. Gonzalez F.A., Seth A., Raden D.L., Bowman D.S., Fay F.S., Davis R.J. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell Biol. 122:1993;1089-1101.
35. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
36. Stacey D.W., Feig L.A., Gibbs J.B. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11:1991;4053-4064.
37. Khokhlatchev A.V., Canagarajah B., Wilsbacher J., Robinson M., Atkinson M., Goldsmith E., Cobb M.H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:1998;605-615.
38. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:1998;49-139.
39. Haneda M., Sugimoto T., Kikkawa R. Mitogen-activated protein kinase phosphatase a negative regulator of the mitogen-activated protein kinase cascade . Eur. J. Pharmacol. 365:1999;1-7.
40. Day R.N., Walder J.A., Maurer R.A. A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J. Biol. Chem. 264:1989;431-436.
41. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:1990;5267-5272.
42. Wang H.G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
43. Adachi M., Fukuda M., Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell Biol. 148:2000;849-856. [published erratum appears in J. Cell Biol. 149(3) (2000) 754].
44. Lenormand P., Brondello J.M., Brunet A., Pouysségur J. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell Biol. 142:1998;625-633.
45. Black E.J., Clark W., Gillespie D.A. Transient deactivation of ERK signalling is sufficient for stable entry into G0 in primary avian fibroblasts. Curr. Biol. 10:2000;1119-1122.
46. Sano M., Kohno M., Iwanaga M. The activation and nuclear translocation of extracellular signal-regulated kinases (ERK-1 and -2) appear not to be required for elongation of neurites in PC12D cells. Brain Res. 688:1995;213-218.
47. Boglari G., Erhardt P., Cooper G.M., Szeberenyi J. Intact Ras function is required for sustained activation and nuclear translocation of extracellular signal-regulated kinases in nerve growth factor-stimulated PC12 cells. Eur. J. Cell Biol. 75:1998;54-58.
48. Yao H., York R.D., Misra-Press A., Carr D.W., Stork P.J.S. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273:1998;8240-8247.